A novel selective prostaglandin-receptor EP4-agonist promotes spinal fusion in rats
Publikation: Beitrag in Fachzeitschrift › Konferenzartikel › Beigetragen
Beitragende
Abstract
A novel EP4 selective agonist (KMN-159) was developed [1] and has been proven that it can act as an osteopromotive factor to repair critical-size femoral bone defects in rats at a dose-dependent manner [2]. Based on its osteopromotive properties, we hypothesized that KMN-159 could also aid in bone formation for spinal fusion. Therefore, the aim of this study was to investigate its spinal fusion effect in a dorsolateral spinal fusion model in rats. This study was performed on 192, 10-week-old male Wistar rats. The rats were randomized into 8 groups (n = 12 per group): 1) SHAM (negative control), 2) MCM (scaffold only), 3) MCM + 20 µg BMP-2 (positive control), 4-8) MCM + 0.2, 2, 20, 200 or 2000 µg KMN-159. A posterolateral intertransverse process spinal fusion at L4 to L5 was performed bilaterally by implanting group dependent scaffolds (see above) or left empty in the SHAM group (protocol no. 25-5131/474/38). Animals were euthanized after 3 weeks and 6 weeks for µCT and biomechanical testing analysis. The results showed that KMN-159 promoted new bone formation in a dose-dependent manner at 3 weeks and 6 weeks as verified by µCT. The biomechanical testing showed that the dose of 20, 200 and 2000 µg KMN-159 groups obtained comparable strength with BMP-2 group, which higher than SHAM, MCM and lower doses of 0.2 and 2 µg KMN-159 groups. In conclusion, KMN-159 could be a potential replacement of BMP-2 as a novel osteopromotive factor for spinal fusion. Acknowledgements: We are grateful to Ulrike Heide, Anna-Maria Placht (assistance with surgeries) as well as Suzanne Manthey & Annett Wenke (histology).
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 112-112 |
Seitenumfang | 1 |
Fachzeitschrift | Orthopaedic Proceedings |
Jahrgang | 106-B |
Ausgabenummer | SUPP_2 |
Publikationsstatus | Veröffentlicht - 2 Jan. 2024 |
Peer-Review-Status | Nein |
(Fach-)Tagung
Titel | 31st Annual Meeting of the European Orthopaedic Research Society |
---|---|
Kurztitel | EORS 2023 |
Veranstaltungsnummer | 31 |
Dauer | 27 - 29 September 2023 |
Bekanntheitsgrad | Internationale Veranstaltung |
Ort | Porto Congress Centre – Alfândega |
Stadt | Porto |
Land | Portugal |
Externe IDs
ORCID | /0000-0003-2834-8933/work/164618194 |
---|---|
ORCID | /0000-0002-8854-7726/work/164619276 |
unpaywall | 10.1302/1358-992x.2024.2.112 |